Biodesix, Inc. - Laporan Laba Rugi (TTM)

Biodesix, Inc.
US ˙ NasdaqGM ˙ US09075X1081

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Biodesix, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 27 46 69 77 74 55 32 31 36 38 41 42 44 49 55 61 66 71 74 77
Change (%) 70.00 52.18 11.03 -3.46 -26.65 -40.95 -2.90 14.64 6.65 6.56 2.26 5.72 11.50 11.74 11.04 7.65 8.79 4.40 2.81
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 9 22 39 44 43 31 16 12 13 14 14 13 13 13 13 14 15 16 16 16
Change (%) 139.73 75.63 13.49 -2.67 -28.49 -49.10 -19.99 7.33 6.09 -0.47 -5.27 -3.03 0.53 0.05 4.91 6.96 6.63 3.39 0.96
% of Revenue 34.24 48.29 55.73 56.96 57.43 55.99 48.26 39.77 37.24 37.04 34.60 32.05 29.40 26.50 23.73 22.42 22.28 21.83 21.62 21.23
Gross Operating Profit 18 24 31 33 32 24 17 19 22 24 27 28 31 36 42 47 51 56 58 60
Change (%) 33.68 30.28 7.93 -4.51 -24.17 -30.58 13.03 19.47 6.98 10.70 6.25 9.85 16.06 15.95 12.94 7.85 9.41 4.69 3.32
% of Revenue 65.76 51.71 44.27 43.04 42.57 44.01 51.74 60.23 62.76 62.96 65.40 67.95 70.60 73.50 76.27 77.58 77.72 78.17 78.38 78.77
SG&A 29 35 39 43 49 51 53 57 58 61 66 67 68 67 69 72 76 80 80 83
Change (%) 18.76 11.04 11.86 13.23 3.05 5.07 7.18 2.65 5.25 7.32 2.15 0.57 -0.55 2.33 4.36 6.28 5.19 -0.13 3.42
% of Revenue 109.52 76.51 55.83 56.25 65.97 92.68 164.90 182.02 162.98 160.84 161.99 161.81 153.91 137.28 125.72 118.16 116.66 112.80 107.90 108.54
R&D 10 11 11 12 13 13 13 13 12 13 13 13 12 10 9 8 9 10 10 11
Change (%) 5.90 3.89 10.82 4.71 -1.94 -0.90 0.30 -2.54 5.76 0.34 -3.43 -8.13 -14.37 -12.12 -4.01 7.23 5.81 8.68 6.84
% of Revenue 38.12 23.75 16.21 16.18 17.55 23.46 39.37 40.67 34.58 34.29 32.29 30.49 26.49 20.35 16.00 13.83 13.78 13.40 13.95 14.50
OpEx 49 68 89 100 105 94 81 82 84 89 93 93 92 90 91 94 100 106 107 110
Change (%) 38.84 30.89 12.44 5.17 -10.42 -13.36 0.91 2.55 5.46 5.05 0.24 -1.13 -2.15 0.40 3.63 6.46 5.45 1.18 3.38
% of Revenue 181.88 148.55 127.77 129.39 140.95 172.14 252.54 262.47 234.79 232.17 228.88 224.35 209.80 184.13 165.45 154.42 152.71 148.03 143.47 144.27
Operating Income -22 -22 -19 -23 -30 -39 -49 -51 -48 -51 -52 -52 -48 -41 -36 -33 -35 -34 -32 -34
Change (%) 0.79 -12.95 17.52 34.51 29.20 24.87 3.42 -4.89 4.58 3.91 -1.33 -6.64 -14.57 -13.08 -7.68 4.28 -0.87 -5.52 4.70
% of Revenue -81.88 -48.55 -27.77 -29.39 -40.95 -72.14 -152.54 -162.47 -134.79 -132.17 -128.88 -124.35 -109.80 -84.13 -65.45 -54.42 -52.71 -48.03 -43.47 -44.27
Interest Expense -8 -8 -7 -5 -4 -5 -5 -6 -7 -8 -9 -10 -10 -10 -10 -9 -9 -8 -7 -7
Change (%) -3.77 -10.60 -28.96 -23.03 21.28 10.78 10.63 27.02 15.02 15.54 11.62 -6.27 -2.27 1.45 -5.11 -3.76 -6.53 -10.22 -0.51
% of Revenue -29.49 -16.69 -9.81 -6.27 -5.00 -8.27 -15.52 -17.68 -19.59 -21.12 -22.90 -25.00 -22.16 -19.43 -17.64 -15.07 -13.48 -11.58 -9.96 -9.63
Net Income -33 -31 -29 -32 -34 -43 -52 -56 -58 -65 -69 -66 -63 -52 -47 -45 -44 -43 -40 -41
Change (%) -5.97 -8.75 10.96 8.41 25.43 19.98 8.54 3.89 12.08 4.76 -3.60 -4.16 -17.68 -9.76 -5.41 -1.55 -2.03 -5.85 1.63
% of Revenue -124.42 -68.81 -41.26 -41.24 -46.31 -79.18 -160.88 -179.84 -162.97 -171.27 -168.38 -158.72 -143.88 -106.23 -85.80 -73.08 -66.84 -60.19 -54.28 -53.66

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista